UnitedHealth Group (UNH) Stock Forecast & Price Target

$388.42 +5.94 (+1.55%)

Closing price 03:59 PM Eastern

Extended Trading

$387.90 -0.52 (-0.13%)

As of 04:31 PM Eastern

Compare

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 27 Analyst Ratings

Sell
1

Hold
6

Buy
20

Based on 27 Wall Street analysts who have issued ratings for UnitedHealth Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 27 analysts, 1 has given a sell rating, 6 have given a hold rating, 19 have given a buy rating, and 1 has given a strong buy rating for UNH.

Consensus Price Target

$387.57
-0.22% Downside

According to the 27 analysts' twelve-month price targets for UnitedHealth Group, the average price target is $387.57. The highest price target for UNH is $460.00, while the lowest price target for UNH is $287.00. The average price target represents a forecasted downside of -0.22% from the current price of $388.42.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for UNH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UNH Analyst Ratings Over Time

Type	Current Forecast 5/22/25 to 5/22/26	1 Month Ago 4/22/25 to 4/22/26	3 Months Ago 2/21/25 to 2/21/26	1 Year Ago 5/22/24 to 5/22/25
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	19 Buy rating(s)	19 Buy rating(s)	17 Buy rating(s)	17 Buy rating(s)
Hold	6 Hold rating(s)	7 Hold rating(s)	9 Hold rating(s)	6 Hold rating(s)
Sell	1 Sell rating(s)	2 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$387.57	$377.68	$372.13	$441.87
Forecasted Upside	-0.22% Downside	6.84% Upside	28.27% Upside	49.05% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

UNH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

UNH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

UnitedHealth Group Stock vs. The Competition

Type	UnitedHealth Group	Medical Companies	Broader Market
Consensus Rating Score	2.74	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	-0.05% Downside	1,725.92% Upside	15.15% Upside
News Sentiment Rating	Positive News See Recent UNH News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/22/2026	UBS Group 4 of 5 stars	A.J. Rice Not Rated	Boost Target	Buy	$410.00 ➝ $460.00	+18.10%
5/20/2026	Mizuho 4 of 5 stars	Ann Hynes 2 of 5 stars	Boost Target	Outperform	$410.00 ➝ $440.00	+13.06%
5/7/2026	Weiss Ratings Not Rated		Upgrade	Sell (D+) ➝ Hold (C-)
4/28/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lisa Gill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$389.00 ➝ $420.00	+14.03%
4/27/2026	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold ➝ Buy
4/23/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Langston Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Hold	$311.00 ➝ $337.00	-4.67%
4/22/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erin Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$375.00 ➝ $395.00	+11.42%
4/22/2026	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Whit Mayo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$345.00 ➝ $400.00	+12.34%
4/22/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Hendrix Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$361.00 ➝ $400.00	+12.34%
4/22/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$370.00 ➝ $397.00	+11.49%
Get the Latest News and Ratings for UNH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors with MarketBeat's FREE daily newsletter.
4/22/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Wiederhorn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$385.00 ➝ $405.00	+13.95%
4/22/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$327.00 ➝ $373.00	+5.30%
4/22/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Ha Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Underperform	$278.00 ➝ $287.00	-18.98%
4/22/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$370.00 ➝ $395.00	+14.08%
4/22/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Toung Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Hold ➝ Buy	$400.00	+15.52%
4/20/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Windley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$340.00 ➝ $373.00	+15.26%
4/7/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lance Wilkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$405.00 ➝ $411.00	+35.75%
4/7/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Reduce ➝ Hold	$300.00	+6.59%
4/1/2026	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Ransom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$330.00	+22.11%
1/28/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Gillmor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight
1/27/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jessica Tassan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight
1/6/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong-Buy
10/29/2025	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Buy ➝ Hold	$333.00	-9.69%
10/14/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Fidel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy	$406.00	+13.15%
10/8/2025	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Fischbeck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$350.00 ➝ $390.00	+5.29%
10/6/2025	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong Sell ➝ Hold
8/26/2025	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$440.00	+44.13%
5/20/2025	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Justin Lake Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$501.00 ➝ $390.00	+21.90%
5/19/2025	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Langston Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$520.00 ➝ $308.00	-1.39%
12/5/2024	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Overweight	$605.00 ➝ $675.00	+10.54%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 04:17 PM ET.

Should I Buy UnitedHealth Group Stock? UNH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, May 21, 2026. Please send any questions or comments about these UnitedHealth Group pros and cons to contact@marketbeat.com.

UnitedHealth Group
Bull Case

Here are some ways that investors could benefit from investing in UnitedHealth Group:

The company recently reported a revenue of $111.65 billion for the quarter, exceeding analyst estimates, indicating strong financial performance.
UnitedHealth Group has set its FY 2026 guidance at an earnings per share (EPS) of 18.250, suggesting confidence in future profitability.
The current stock price is around $355, which reflects a solid position in the market and potential for growth.
Analysts have a consensus rating of "Moderate Buy" for the stock, with a price target of approximately $381.48, indicating positive sentiment among market experts.
The company has a consistent dividend payout, with a recent quarterly dividend of $2.21, representing an annualized yield of 2.3%, which can provide income to investors.

UnitedHealth Group
Bear Case

Investors should be bearish about investing in UnitedHealth Group for these reasons:

The recent exit of Berkshire Hathaway from its investment in UnitedHealth Group may raise concerns among other investors about the company's long-term prospects.
There are ongoing pressures from rising medical costs and changes in member mix, which could impact future earnings negatively.
Despite positive earnings, the stock has experienced volatility, which may deter risk-averse investors.
Recent analyst ratings show a mix of opinions, with one analyst issuing a "Sell" rating, indicating some uncertainty in the market.
Proposed healthcare legislation could introduce uncertainties that may affect the insurance sector, including UnitedHealth Group, in the long run.

UNH Forecast - Frequently Asked Questions

According to the research reports of 27 Wall Street equities research analysts, the average twelve-month stock price forecast for UnitedHealth Group is $387.57, with a high forecast of $460.00 and a low forecast of $287.00.

27 Wall Street analysts have issued "buy," "hold," and "sell" ratings for UnitedHealth Group in the last twelve months. There is currently 1 sell rating, 6 hold ratings, 19 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" UNH shares.

According to analysts, UnitedHealth Group's stock has a predicted downside of -0.22% based on their 12-month stock forecasts.

Over the previous 90 days, UnitedHealth Group's stock had 5 upgrades and 1 downgrade by analysts.

UnitedHealth Group has been rated by research analysts at Argus, Barclays, Erste Group Bank, HSBC, Jefferies Financial Group, JPMorgan Chase & Co., Leerink Partners, Mizuho, Morgan Stanley, Oppenheimer, Raymond James Financial, Robert W. Baird, Royal Bank Of Canada, Sanford C. Bernstein, TD Cowen, Truist Financial, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like UnitedHealth Group more than other "medical" companies. The consensus rating for UnitedHealth Group is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how UNH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With UnitedHealth Group Recommendations

This page (NYSE:UNH) was last updated on 5/22/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

UNH Analyst Ratings Over Time

UNH Analyst Recommendations By Month

UNH Price Targets by Month

UnitedHealth Group Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy UnitedHealth Group Stock? UNH Pros and Cons Explained

UnitedHealth Group
Bull Case

UnitedHealth Group
Bear Case

UNH Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With UnitedHealth Group Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

UNH Analyst Ratings Over Time

UNH Analyst Recommendations By Month

UNH Price Targets by Month

UnitedHealth Group Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy UnitedHealth Group Stock? UNH Pros and Cons Explained

UnitedHealth Group Bull Case

UnitedHealth Group Bear Case

UNH Forecast - Frequently Asked Questions

What is UnitedHealth Group's forecast for 2026?

Should I buy or sell UnitedHealth Group stock right now?

Does UnitedHealth Group's stock price have much downside?

Has UnitedHealth Group been upgraded or downgraded by Wall Street analysts recently?

What analysts cover UnitedHealth Group?

Do Wall Street analysts like UnitedHealth Group more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With UnitedHealth Group Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

UnitedHealth Group
Bull Case

UnitedHealth Group
Bear Case